Status:
UNKNOWN
Registry for a Cardiovascular Patient Who COVID-19 Infection in Qatar and Gulf
Lead Sponsor:
Hamad Medical Corporation
Conditions:
Cardiovascular Diseases
Eligibility:
All Genders
Brief Summary
The novel coronavirus, severe acute respiratory syndrome coronavirus 2, that causes coronavirus disease 2019 (COVID -19), is highly contagious in the community and has resulted in a global pandemic. T...
Detailed Description
The primary objective of this registry is to create a database of patients who present with acute cardiovascular and are found to be COVID -19 positive (by PCR). The registry will consist of four arms...
Eligibility Criteria
Inclusion
- Patients who admitted to the heart hospital or any other hospital with acute cardiovascular condition.
- Patient with confirming or suspicious of COVID-19 infection
- Patient who admitted to any hospital in the Gulf and has Acute MI with confirm or suspicious of COVID-19 infection
Exclusion
- N/A
Key Trial Info
Start Date :
June 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04430374
Start Date
June 2 2020
End Date
December 31 2020
Last Update
June 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamad Medical Corporation
Doha, Unlisted (UL), Qatar, 974